| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |